CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

The BRILLIANCE study of EDIT-101 in Leber congenital amaurosis type 10 (LCA10) – an inherited form of blindness – was reported to be the first 'in vivo' CRISPR/Cas9 medicine to be administered ...

The Seattle Seahawks are going into their 16th NFL draft with John Schneider as their general manager. While this front office has had its weak points - such as the offensive line - the results ...

In the closing of the recent trading day, CRISPR Therapeutics AG (CRSP) stood at $38.54, denoting a -1.76% change from the preceding trading day. Gene therapy developer CRISPR Therapeutics AG ...

that it says build the case for the drug as a phase 3 trial gets underway – but its shares fell sharply as investors reacted to the news. The CRISPR specialist said that a single 50mg infusion ...

Andrew Schneider is the senior reporter for politics and government at Houston Public Media, NPR’s affiliate station in Houston, Texas. In this capacity, he heads the station’s coverage of ...

I consider new PhD students every year. All PhD admissions in the School of Computer Science at Carnegie Mellon are done through a centralized admissions committee. Matching to specific labs and ...

State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China ...